Xinyang Tablet attenuates chronic hypoxia-induced right ventricular remodeling via inhibiting cardiomyocytes apoptosis

Table 1 Formulary identification of the chemical constituents of XYT as determined by HPLC–MS analysis

Number	t_R/min	Name	Formula	Scanning Mode	MS(m/z)	δ/mDa	Adduct Ion
1	0.85	Stachydrine	C₇H₁₃NO₂	ESI+	144.1008	− 1.1	+H
2	1.43	Geniposidic acid	C₁₆H₂₂O₁₀	ESI −	373.1140	0.0	− H
3	2.14	Quercetin	C₁₅H₁₀O₇	ESI+	303.0482	− 1.8	+H
4	3.78	Baohuoside II	C₂₆H₂₈O₁₀	ESI+	251.0906	0.0	+2H
5	5.32	Leonurine	C₁₄H₂₁N₃O₅	ESI+	312.1545	− 0.9	+H
6	6.51	Calycosin-7-O-β-d-glucoside	C₂₂H₂₂O₁₀	ESI −	491.1196	0.1	+HCOO
7	8.23	Verproside	C₂₉H₃₆O₁₅	ESI −	623.1974	− 0.7	− H
8	8.71	Syringaresinol	C₂₂H₂₆O₈	ESI −	417.1530	− 2.5	− H
9	9.13	Plantamajoside	C₂₉H₃₆O₁₆	ESI −	639.1931	0.0	− H
10	11.19	Ginsenoside Rd	C₄₈H₈₂O₁₈	ESI −	991.5493	0.9	+HCOO
11	11.94	Calycosin	C₁₆H₁₂O₅	ESI+	285.0742	− 1.5	+H
12	12.62	Sagittatoside B	C₃₂H₃₈O₁₄	ESI −	645.2188	− 0.1	− H
13	12.89	Epmedin C	C₃₉H₅₀O₁₉	ESI+	823.3022	0.3	+H
14	13.18	Icariin	C₃₃H₄₀O₁₅	ESI+	677.2443	0.3	+H
15	14.46	Ginsenoside Rg1	C₄₂H₇₂O₁₄	ESI −	845.4918	1.4	+HCOO
16	15.60	Ginsenoside Rb1	C₅₄H₉₂O₂₃	ESI −	1107.5974	1.8	− H
17	15.79	20(R)-Ginsenoside Rh1	C₃₆H₆₂O₉	ESI −	683.4382	0.7	+HCOO
18	15.89	Ginsenoside Ro	C₄₈H₇₆O₁₉	ESI −	955.4917	0.9	− H
19	17.06	Isoastragaloside IV	C₄₁H₆₈O₁₄	ESI −	829.4590	− 0.1	+HCOO
20	17.80	Ilexsaponin A1	C₃₆H₅₆O₁₁	ESI −	663.3757	0.7	− H
21	23.53	Ilexgenin A	C₃₀H₄₆O₆	ESI −	501.3224	0.2	− H

ISSN: 1749-8546